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Background: This study aimed to evaluate the quality of the current clinical practice guidelines (CPGs) in traditional
medicine (TM) in South Korea using the Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument
to further enhance the CPG development.
Methods: A search was performed for guidelines in Korea from inception until March 2014 in the major Korean
guideline websites [the Korean Medical Guideline Information Centre (KoMGI), the Korean Guideline Clearing House
(KGC)], PubMed and seven Korean electronic databases; the Association of Korean Oriental Medicine (AKOM) was also
consulted. Five independent assessors rated the quality of each CPG using the AGREE II instrument and calculated the
mean score of each AGREE item. The overall agreement amongst reviewers was evaluated using the intra-class
correlation coefficient (ICC).
Results: Initially, 17 CPGs were examined for TM in Korea, and only 8 CPGs satisfied the inclusion criteria. The mean
scores for each AGREE II domain were as follows: (1) scope and purpose, 60.0 % (CIs, 45.05-74.94 %); (2) stakeholder
involvement, 56.11 % (41.28-70.94 %); (3) rigour of development, 42.7 % (23.48-61.92 %); (4) clarity and presentation,
62.50 % (50.89-74.10 %); (5) applicability, 20.31 % (13.96-26.66 %); and (6) editorial independence, 44.58 % (10.78-78.38 %).
All of the CPGs were rated as “recommended with provisos or modifications”. The ICC values for CPG appraisal using the
AGREE II ranged from 0.230 to 0.993.
Conclusions: To improve clinical practice and health outcomes, well-developed CPGs are needed. The quality of CPGs for
TM in Korea has remained suboptimal according to the AGREE II instrument evaluation. Therefore, guideline developers in
Korea should make more of an effort to ensure high-quality CPGs.
Keywords: Clinical practice guideline (CPG), Korean traditional medicine, Appraisal of Guideline for Research and
Evaluation (AGREE) II, Quality assessment, Evidence-based medicine (EBM)Background
Clinical practice guidelines (CPGs) are systematically de-
veloped statements to assist practitioner and patient de-
cisions about appropriate health care for specific clinical
circumstances [1, 2]. CPGs have the potential to influ-
ence the care delivered by healthcare providers and the
outcomes of patients [3]. Therefore, the quality of CPGs is
critically important. Whereas guidelines were initially based
on consensus amongst experts, guideline development has* Correspondence: drmslee@gmail.com
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creativecommons.org/publicdomain/zero/1.0/been gradually formalised and now consists of evidence-
based guidelines [4]. Evidence-based CPGs ensure that the
document or recommendation has been created using an
unbiased and transparent process of systematically review-
ing, appraising and using the best clinical research findings
of the highest value to aid in the delivery of optimum clin-
ical care to patients. Evidence-based CPGs can be used to
develop quality measures and to support referrals when
they are questioned by insurance companies; these CPGs
also serve as education tools for patients.
The Appraisal of Guidelines for Research and Evalu-
ation (AGREE) instrument was published by a group ofle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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The purpose of the AGREE is to provide a framework
for assessing the quality of guidelines, provide a meth-
odological strategy for the development of guidelines
and inform what information and how information
ought to be reported in guidelines [6]. Many countries
have adopted the AGREE instrument to assess and valid-
ate the quality of CPGs, including CPGs for the manage-
ment of particular diseases [7–10].
In Korea, developing clinical practice guidelines began
approximately 10 years ago and resulted in increased
interest in the development of CPGs in the healthcare
community [11]. The Korean Medical Guideline Infor-
mation Centre (KoMGi) [12], which opened in 2008, is a
very useful nationwide dissemination tool of CPGs for
health professionals. The Korean guideline clearing-
house (KGC) includes approximately 80 CPGs that have
been developed by 40 Western Medical Associations in
Korea. Although Western medicine has established
quality evaluations of CPGs using the AGREE, the ef-
forts to evaluate CPGs in Korea were not sufficient [13].
South Korea has maintained a dual healthcare delivery
system that incorporates both traditional Korean and
Western medicine. Traditional medicine (TM) in Korea
remains in the beginning stage of development, and the
use of CPGs is limited. Currently, only 17 CPGs are
available regarding TM (Table 1). The CPGs are mixed
with training manuals and textbook-like publications,
and the aim of the CPGs is very unclear. The CPGs for
TM have mostly been developed by the members of the
Association of Korean Oriental Medicine (AKOM).
Compared to Western medicine, the clinical diagnosis
and treatment in TM is less consistent, and the stan-
dards are poorer. In our previous study, which was a
survey of Korean medical doctors concerning their per-
ceptions of the development of CPGs for TM via e-mail,
the results suggested the need to develop CPGs and to
establish evidence in clinical practice and provide health-
care standards in TM [14]. It is necessary to evaluate the
assessments of CPGs before developing these guidelines.
In other words, a thorough understanding and investiga-
tion of the current status of CPGs is essential for quality
management of CPGs in TM [15]. However, little is
known about the quality of CPGs for TM. Therefore, the
assessment of CPGs for TM is urgently required. To the
best of our knowledge, no study has investigated the
evaluation of CPGs of TM based on the AGREE instru-
ment, although CPG development is regularly researched
in Korea.
Considering these needs, this study aimed to investi-
gate the current state of CPGs for TM through evaluat-
ing the quality of evidence-based guidelines in TM using
the AGREE II instrument and to identify their quality to
further enhance CPG development.Methods
Study design
This study conducted a review of CPGs using the
AGREE II instrument.
Review protocol
This study was performed in accordance with the guide-
lines from the preferred reporting items for systematic
reviews and meta-analyses (PRISMA) [16].
Literature search
The CPG searches were conducted in March 2014 in major
Korean guideline websites [the KoMGI and the KGC].
PubMed was searched as an international database, and
KoreaMed, the Korea Institute of Science and Technology
Information (KISTI), DBpia, the Korea National Assembly
Library, the Korean Studies Information Service System
(KISS) and the Oriental Medicine Advanced Searching
Integrated System (OASIS) were searched as domestic
databases.
Other sources such as contact with the AKOM and
the Society of Korean Medicine were utilised to receive
information on CPGs; additionally, the reference lists of
all the obtained papers were searched. Hard copies of all
the articles were obtained and read in full. The search
terms were (clinical or practice or diagnosis or treatment or
therapy or medication or drug or operation or prevention
or management) and (guideline* or recommendation or
consensus) and (traditional medicine or Korean medicine).
The strategy of Korean search terms is shown in Additional
file 1. Data regarding details such as development groups,
financial source, development year and update status were
collected for each document identified as a CPG (Table 1).Inclusion and exclusion criteria
The included CPGs in this study were original reports pub-
lished in Korea that described TM interventions and pro-
vided sufficient methodological details based on evidence.
The inclusion criteria were as follows: (1) Korean lan-
guage CPGs, which were produced by mainland Korea
organisations, and (2) based on a systematic review of
relevant research evidence. To determine whether the
guidelines were evidence-based, we investigated whether
they reported a search strategy, quality and data extrac-
tion that classified the evidence quality and graded the
strength of the recommendation. If the CPGs had up-
dates, only the most recent version was assessed.
CPGs were excluded if they met any of the following
criteria: systematic reviews, narrative reviews, primary
studies, critical pathways, training manuals for medical
doctors, textbook-like publications, guidelines for pa-
tients, editorials, translations of foreign guidelines, sec-
ondary or multiple publications and short summaries.
Table 1 Summary of developed guidelines in TM




1 Cervical vertebral portion Acupuncture AKOM AKOM Training manuals 2007
Moxibustion
Chuna
2 Lumbar vertebrae Herbal medicine AKOM AKOM Training manuals 2007
Acupuncture
Moxibustion











Herbal medicine AKOM AKOM Training manuals 2009




6 Non-smoking Acupuncture AKOM AKOM Training manuals 2010
7 Whiplash injury-associated
disorders (WAD)
Chuna Korean Society of Chuna
Manual Medicine for
Spine and Nerves





8 High blood hypertension Herbal medicine AKOM AKOM Text-like 2010
9 Diabetes Herbal medicine AKOM AKOM Text-like 2010
10 Cold Herbal medicine AKOM AKOM Text-like 2011
























15 Atopic dermatitis Herbal medicine The Society of Korean Medical
Ophthalmology, Otolaryngology
and Dermatology
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Table 1 Summary of developed guidelines in TM (Continued)
16 Bell’s palsy Herbal medicine Korean Acupuncture and
Moxibustion Medicine Society






17 Lumbar HIVD Herbal medicine The Korean Academy
of Oriental Rehabilitation Medicine







AKOM Association of Korean Oriental Medicine, CPG clinical practice guideline, HIVD herniated intervertebral disc, KIOM Korea Institute of Oriental Medicine
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The AGREE II instrument is a tool used to assess the
methodological quality of evidence-based CPGs [5, 6]. It
was translated into Korean to reduce inter-rater differ-
ence by Korean medical societies in 2011 [17]. The
AGREE II consists of 23 items grouped into 6 domains
and 1 overall assessment item: (1) scope and purpose
(items 1–3)—the objective of the guideline, the target
population and the health question; (2) stakeholder in-
volvement (items 4–6)—involvement of stakeholders in
the guideline development process and patients’ views and
preferences; (3) rigour of development (items 7–14)—the
process to collect and synthesise evidence and the rec-
ommendation development process; (4) clarity and
presentation (items 15–18)—the language, structure
and presentation of the guideline; (5) applicability (items
19–21)—evaluating the barriers and facilitators for the im-
plementation and approach to improve uptake; and (6)
editorial independence (items 22–23)—identifying biases
resulting from competing interests. The overall assess-
ment includes the rating of the overall quality of the
guideline and whether the guideline would be recom-
mended for use in practice. Each of the AGREE II items
and the two global rating items were rated on a seven-
point scale (1—strongly disagree to 7—strongly agree). A
score was assigned depending on the completeness and
quality of reporting. Domain scores were calculated by
summing all the scores of the individual items in a domain
and by scaling the total as a percentage of the maximum
possible score for that domain. The scaled domain score
was calculated as (obtained score −minimum possible
score)/(maximum possible score −minimum possible
score). The overall AGREE II evaluations (recommend,
recommend with modifications or do not recommendeach guideline) were independently determined by each
assessor; then, consensus was achieved.
Quality appraisal of guidelines
Each guideline should be assessed by at least two ap-
praisers to increase the reliability of the assessment ac-
cording to AGREE II. There were five appraisers with
experience in the quality assessment of CPGs in this study
who independently scored each guideline using the
Korean translated AGREE II instrument. To improve the
quality of the appraisal of guidelines, the CPG evaluation
was pilot tested with the reviewers. All five appraisers, in-
cluding a guideline methodologist, clinician and research
assistant, received a training seminar and workshop that in-
cluded education on the guideline development methods
and the process and application of AGREE II. Additionally,
we used the Korean-translated AGREE II. One study had
examined the effect of the Korean AGREE II scoring guide
and showed that the scoring guide reduced the inter-rater
disagreement and improved the overall reliability [18].
Investigation of heterogeneity
The scores of the five appraisers were used to calculate
an average for each domain, and these scores were
expressed as a percentage. Inter-rater reliability was cal-
culated for each domain of the AGREE instrument using
the intra-class correlation coefficient (ICC) with a 95 %
CI. Statistical analysis was performed using SPSS for
Windows 12.0 (SPSS Inc., Chicago, IL, USA).
Results
Guideline search and review process
A total of 34 articles were considered to be potentially
relevant; after selection, a total of 17 guidelines were
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on a systematic review of the evidence. Nine guidelines
were excluded because they were textbook-like (n = 4),
training manuals for medical doctors (n = 4) or a review
(n = 1) (Table 1). Finally, eight guidelines meeting our in-
clusion criteria were included, covering a period from
2010 to 2013 (Fig. 1 and Table 1).
Guideline characteristics
A total of eight CPGs were eligible. The data from all of
the included CPGs are listed. The eight CPGs focused on
the following conditions: low fertility [19], Hwa-byung
[20], knee pain [21], low back pain [22], neck pain [23],
atopic dermatitis [24], Bell's palsy [25] and lumbar herni-
ated intervertebral disc (HIVD) [26]. All eight CPGs wereFig. 1 PRISMA diagram for the included studies. AKOM Association of Koredeveloped by academic societies. Specifically, the literal
meaning of Hwa-byung is “anger disease” or “fire disease”,
which is known as a culture-related syndrome related to
anger in Korea [27]. In terms of funding, seven guidelines
were supported by the Korean government, and another
CPG reported receiving AKOM funding. Only one CPG
was developed specifically for female adults, and the rest
were for all adults. All CPGs stated that the recommenda-
tions were based on evidence. However, there was sub-
stantial variation in the grading systems of evidence
quality and the recommendation strength (Table 2).
Appraisal of the AGREE II domains of the guidelines
The results of the assessments using the AGREE instru-
ment are shown in Table 3 and Additional file 2.an Medicine, CPGs clinical practice guidelines
Table 2 Characteristics of eight evidence-based guidelines
Guidelines by medical
condition [ref]
Target population Method to formulate
recommendations
Quality of evidence Strength of recommendations
Low fertility [19] Female adult Based on SR of available evidence Modified SIGN Modified SIGN
Consensus development
based on evidence
Hwa-byung (火病) [20] Adult Based on SR of available evidence UMHS [43] UMHS [43]
Consensus development
based on evidence
Based on available data
Knee pain [21] Adult Based on SR of available evidence NZGG grading system in
accordance with the CAM
Clinical practice guidelines
for acupuncture [44]





Atopic dermatitis [24] Adult Based on SR of available evidence Modified SIGN Modified SING
Bell’s palsy [25] Consensus development
based on evidence
Modified Evidence-based guideline
of clinical practice in Chinese
medicine internal China
Modified Evidence-based




CAM complementary and alternative medicines, NZGG New Zealand Guidelines Group, SIGN Scottish Intercollegiate Guideline Network, SR systematic review,
HIVD herniated intervertebral disc, UMHS University of Michigan Health System
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This domain evaluates the overall objectives, expected
benefits or outcomes and target population of the guide-
lines. The mean score for this domain was 60.0 % (CIs,
45.05-74.94). Three CPGs [24–26] scored >60 % (Table 3).
In four CPGs [19, 21–23], the overall objectives were not
specifically described.
Stakeholder involvement
This domain evaluates the degree of relevant profes-
sional group involvement, whether the views and pref-
erences of the target population have been considered
and whether the definition of target users has been










Low fertility [19] 45.56 36.67 22.92
Hwa-byung (火病) [20] 48.89 61.11 18.33
Knee pain [21] 45.56 41.11 31.25
Low back pain [22] 46.67 38.89 28.33
Neck pain [23] 48.89 44.44 30.83
Atopic dermatitis [24] 78.89 73.33 70.00
Bell’s palsy [25] 83.33 76.67 70.00
Lumbar HIVD [26] 82.22 76.67 70.00






AGREE Appraisal of Guidelines for Research and Evaluation, CI cofidence interval, CP
aNR not recommended, R recommended with provisos or modifications, SR stronglylow with a mean of 56.11 % (CIs, 41.28-70.94). Three
CPGs [24–26] scored >60 % (Table 3). Five CPGs [19–23]
reported only the names and the institutional affiliation
of the participants, and three CPGs [24–26] explicitly
described the information about the area or discipline
of the professionals. No CPG stated that the patients’
values or preferences were considered.
Rigour of development
This domain addresses the method of evidence search,
grading, summary and the formulation of the recom-
mendations. The mean score for this domain was 42.7 %
(CIs, 23.48-61.92 %). Three CPGs [24–26] scored >60 %







53.33 12.50 1.67 R
44.44 15.00 13.33 R
55.56 16.67 21.67 R
55.56 13.33 21.67 R
55.56 17.5 20.00 R
80.00 30.00 93.33 R
81.11 30.83 91.67 R








Gs clinical practice guidelines
recommended, U unsure
Table 4 Inter-rater reliability for each quality domain
Domains ICC (95 % CI)
Scope and purpose 0.956 (0.878–0.990)
Stakeholder involvement 0.940 (0.833–0.986)
Rigour of development 0.986 (0.962–0.997)
Clarity and presentation 0.904 (0.734–0.978)
Applicability 0.230 (−1.143–0.824)
Editorial independence 0.993 (0.981–0.998)
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dations. By contrast, all the CPGs used systematic
methods to search for evidence. Three CPGs [24–26]
declared that they will be updated when new important
evidence appears, whereas only four provided a time-
line for updating.
Clarity and presentation
This domain generally evaluates the presentation and
format of guidelines. The mean score was 62.50 % (CIs,
50.89-74.10 %), which was relatively higher than the
other domains. Three CPGs [24–26] scored >60 %
(Table 3). The key recommendations were easy to iden-
tify in most CPGs, but the clarity of the recommenda-
tions must be improved.
Applicability
This domain evaluates the consideration of facilitators
or barriers to CPG implementation and monitoring cri-
teria. The mean score of this domain was 20.31 % (CIs,
13.96-26.66 %), which was the lowest of all the domains.
All the CPGs scored <60 %. All the CPGs failed to suffi-
ciently consider applicability in guideline development.
Editorial independence
This domain addresses issues and competing interests
of the guideline development members. The mean score
was 44.58 % (CIs, 10.78-78.38 %). Three CPGs [24–26]
scored >60 % (Table 3). Seven CPGs [20–26] reported
receiving government funding, and only one CPG [19]
reported receiving AKOM funding. Only three CPGs
declared the potential conflicts of interest (COI) of the
guideline developers.
Overall assessment
This assessment concerns “the rating of body quality of
the guidelines and whether the guideline would be rec-
ommended for use in practice”. According to the ap-
praisal of the individual domains and overall scores, all
the CPGs were rated as “recommended with provisos or
modifications”.
Consistency
The ICC values for the AGREE II instrument appraisal
are listed in Table 4. The ICC values, which indicate the
overall agreement between reviewers, generally received
higher reliability scores. The ICC values for CPG ap-
praisal using the AGREE II ranged from 0.230 to 0.993.
The ICCs for the AGREE appraisal conducted by the five
raters were lowest in the “applicability” domain (0.230)
but higher in the “scope and purpose”, “stakeholder in-
volvement”, “rigour of development”, “clarity and presen-
tation” and “editorial independence” domains (all >0.9).Discussion
This study is the first to examine the quality of CPGs for
TM in Korea using the AGREE II assessment tool. Our
results showed that CPGs for TM are of moderate qual-
ity, which varies greatly between guidelines and across
domains (Table 3). Currently, only eight evidence-based
CPGs are available in TM in Korea. Thus, there have
been few studies regarding CPGs, and little is known
about their status. Particularly, the domains “rigour of
development”, “applicability” and “editorial independ-
ence” were rated as low quality.
Three recently developed CPGs [24–26] received a
strong score on the AGREE II. The development groups
involved methodological experts who ensured that meth-
odological checks were correctly applied and that the
development process itself was fully documented. There-
fore, methodological training should be established for
guideline development groups to increase familiarity with
guideline development standards such as the AGREE in-
strument and to incorporate these standards into CPGs.
Since 2006 in China, with the support of the World
Health Organization/Western Pacific Regional Office
(WHO/WPRO), multidiscipline panels were convened by
the China Academy of Chinese Medical Sciences (CACMS)
to develop the first collection of evidence-based CPGs in
traditional Chinese medicine (TCM) [28–30]. These CPGs
were also assessed using the AGREE instrument and
showed a similar quality compared to the Korean CPGs for
TM. In particular, evidence-based CPGs in TCM had the
lowest score for applicability (27.09 %) compared to the
other domains. Our AGREE II assessment also showed
that the average score for applicability (20.31 %) was
the lowest of the six domains. The applicability domain
contains items about organisational barriers, resource
implications for recommendations and key review cri-
teria for monitoring and/or audit purposes. Most CPGs
did not consider organisational barriers to CPG imple-
mentation and did not supply monitoring criteria to
assess the CPGs’ effect.
Most domains showed a high reliability. Thus, inter-
appraiser scores showed a strong correlation, and values
were high for most domains except for the domain applic-
ability. Because there were few or no implementation
strategies or efforts to promote implementation in Korea,
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praisers are thought to affect inter-rater differences [13].
Future CPGs should suggest that special attention be paid
to enhance the quality of applicability in developing
evidence-based CPGs in TM.
In this study, all the CPGs used different grading sys-
tems to assess the quality of evidence and recommenda-
tions (Table 2). Specifically, there was a lack of strong
relevance between the quality of evidence and the
strength of recommendations, and many did not con-
sider the consistency of results amongst the studies [31].
Consequently, many other organisations developed their
own grading systems [28–30, 32]. Recently, the most
widely used and known grading system is the Grading of
Recommendations Assessment, Development and Evalu-
ation (GRADE) [33]. The aim of this group is to develop a
consolidated grading system for evidence quality and
strength of recommendations to suggest that further
CPGs use a comparable uniform grading system to
evaluate the quality of evidence and strength of recom-
mendations. However, there are obvious differences be-
tween the healthcare systems and clinical trial methods of
medical systems [34, 35]. The methods for evaluating evi-
dence and grading recommendations should be estab-
lished according to the characteristics of TM medical
literature [36, 37].
CPGs have been widely developed and support
implementation with the aim of improving health-
care processes and patient outcomes, but the use of
evidence-based practice remains haphazard. CPGs
are both poorly developed and ineffectively implemented.
To improve clinical practice and health outcomes, both
well-developed CPGs and effective methods of CPG im-
plementation are required [38]. Furthermore, there is a
need to develop effective implementation methods to
achieve large-scale adoption of proven innovations and
recommended care [39].
High-quality systematic reviews (SRs) and randomised
controlled trials (RCTs) are sources of the best evidence
[40]. However, evidence-based CPG development is lim-
ited because of insufficient or conflicting evidence of
high-quality SRs and RCTs in TM. Although CPG de-
velopers are frequently required to incorporate more
than one form of evidence in their CPGs, information
and guidance on how to achieve this goal are lacking.
Formal consensus methods (i.e. the Delphi method, the
nominal group technique, the RAND/UCLA Appropri-
ateness Method (RAM) and the National Institutes of
Health (NIH) consensus development conference) or
guideline development are recommended [41]. CPGs
that use informal consensus methods formulate recom-
mendations without drawing on research evidence [42].
The consensus method is a basic method for developing
CPGs in TM and requires further normalisation.This review has a few limitations. Only a few CPGs
regarding TM were found. It was assumed that CPGs
that were not identified in this study have little poten-
tial use in practice. The CPGs evaluated in this report
were primarily retrieved from the AKOM. The search
results were examined in conjunction with a mail sur-
vey of seven clinical academic associations that are not
member societies of the AKOM, which were added
subsequently. Despite these limitations, this review is
useful because it is the first to assess the current CPGs
available in TM, and it evaluates the quality of their
development process.
Several guidelines were produced in Korea within the
last 5 years, but the overall quality was generally low.
There are several recommendations for the future. First,
an educational training programme should be developed
for core confidence of guideline development groups to
further familiarise them with guideline development
standards such as the AGREE instrument and to incorp-
orate these standards into CPGs. Second, budget prepar-
ation and the planning of financial support is required
for developing and disseminating evidence-based CPGs,
and a strategy for efficient partnership between the pri-
vate sector and the government should be formulated
and executed. Third, a methodology for the development
of CPGs based on our TM environment, which lacks sup-
porting evidence, is required, and technical support should
be provided. Finally, future CPGs should use a consistent
grading system to assess the quality of evidence and
strength of recommendations.
In conclusion, the quality of CPGs for TM in Korea
has remained suboptimal according to the AGREE II in-
strument evaluation. Specially, the use of AGREE II in
the development process ensures that these consider-
ations are incorporated and must make an increased
effort to ensure the high quality of CPGs. Therefore,
guideline developers should consider adopting evidence-
based CPGs for developing trustworthy guidelines to
ensure the translation of evidence into practice.
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